Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas

This publication has 42 references indexed in Scilit:

• Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
  1995
• bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
  1993
• Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
  1993
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
  1992
• bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
  1992
• Bcl-2 initiates a new category of oncogenes: regulators of cell death.
  1992
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
  Proceedings of the National Academy of Sciences, 1991
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
  Nature, 1988
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18
  Cell, 1985
• Colorectal carcinoma: Evaluation of histologic grade and factors influencing prognosis
  Journal of Surgical Oncology, 1982